Answers are grounded in this paper and cite their sources.
Case report describes rare RAM acute megakaryoblastic leukemia with CBFA2T3::GLIS2 fusion in an infant, highlighting poor clinical prognosis and unique pediatric genetic profiles.
Acute myeloid leukemia (AML) in pediatric patients is rare compared to adults. Recent updates in the World Health Organization classification (WHO). Indicate that the genetic signatures defined in adult AMLs are classified into different categories. The genetic landscape in pediatric AMLs is also characterized by different fusions, mainly involving the more common translocation t (11; x), resulting in KMT2A rearrangements, and mutations defined by the presence of DNMT3A and other splicing factor genes. Core binding factors are evenly distributed across all age groups. Here, we describe a case of a rare RAM phenotype with acute megakaryoblastic leukemia (AMKL), characterized by a disease-defining fusion and poorer outcomes.
No takes yet. Share an insight, caveat, or question.
Mehrotra et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: